Intimate partner violence in 46 low-income and middle-income countries: an appraisal of the most vulnerable groups of women using national health surveys.

BMJ Global Health
Carolina V N CollAluisio J D Barros

Abstract

Intimate partner violence (IPV) against women is a critical public health issue that transcends social and economic boundaries and considered to be a major obstacle to the progress towards the 2030 women, children and adolescents' health goals in low-income and middle-income countries (LMICs). Standardised IPV measures have been increasingly incorporated into Demographic and Health Surveys carried out in LMICs. Routine reporting and disaggregated analyses at country level are essential to identify populational subgroups that are particularly vulnerable to IPV exposure. We examined data from 46 countries with surveys carried out between 2010 and 2017 to assess the prevalence and inequalities in recent psychological, physical and sexual IPV among ever-partnered women aged 15-49 years. Inequalities were assessed by disaggregating the data according to household wealth, women's age, women's empowerment level, polygyny status of the relationship and area of residence. National levels of reported IPV varied widely across countries-from less than 5% in Armenia and Comoros to more than 40% in Afghanistan. Huge inequalities within countries were also observed. Generally, richer and more empowered women reported less IPV, as well as thos...Continue Reading

References

Apr 30, 2002·Lancet·Rachel Jewkes
Oct 10, 2006·Lancet·Claudia Garcia-MorenoUNKNOWN WHO Multi-country Study on Women's Health and Domestic Violence against Women Study Team
Feb 12, 2008·Journal of Health Care for the Poor and Underserved·Embry Howell, Joshua McFeeters
Dec 18, 2013·American Journal of Epidemiology·Tia PalermoAmber Peterman
Aug 12, 2014·The Lancet Global Health·Emma FuluUNKNOWN UN Multi-country Cross-sectional Study on Men and Violence research team
Dec 4, 2014·Lancet·Claudia García-MorenoCharlotte Watts
Mar 10, 2016·BJOG : an International Journal of Obstetrics and Gynaecology·B M DonovanA F Saftlas
May 6, 2016·Bulletin of the World Health Organization·Jeanne ChaiMary C Smith Fawzi
Apr 12, 2017·The Lancet Global Health·Deborah A Fry, Stuart P Elliott
Aug 2, 2017·The Lancet Global Health·Fernanda EwerlingAluisio J D Barros
Oct 25, 2017·African Health Sciences·Ayotunde TitilayoMartin E Palamuleni
Dec 22, 2017·American Journal of Public Health·Sophie F RedaFalk Schwendicke

❮ Previous
Next ❯

Citations

Jun 18, 2021·Reproductive Health·Yohannes Dibaba WadoCaroline W Kabiru
Jul 14, 2021·Archives of Women's Mental Health·Rehana ShinwariMasood Ali Shaikh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.